Portal systemic collateral development: is it a trophic adaptation mechanism to hepatic deprivation?
Aller
Maria-Angeles
MA
Arias
Jaime
J
D000109:Acetylcholine / Q000494:pharmacology; D000818:Animals; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000494:pharmacology; D000959:Antihypertensive Agents / Q000494:pharmacology; D003097:Collateral Circulation / Q000187:drug effects*; D003135:Common Bile Duct / Q000503:physiopathology / Q000601:surgery; D006975:Hypertension, Portal / Q000503:physiopathology; D007213:Indomethacin / Q000494:pharmacology; D008026:Ligation; D008099:Liver / Q000098:blood supply*; D008106:Liver Cirrhosis, Experimental / Q000378:metabolism* / Q000503:physiopathology*; D008297:Male; D009638:Norepinephrine / Q000494:pharmacology*; D010646:Phentolamine / Q000494:pharmacology; D011168:Portal System / Q000187:drug effects*; D011433:Propranolol / Q000494:pharmacology; D051381:Rats; D017207:Rats, Sprague-Dawley; D012701:Serotonin / Q000494:pharmacology; D014655:Vascular Resistance; D014662:Vasoconstrictor Agents / Q000494:pharmacology*; D014665:Vasodilator Agents / Q000494:pharmacology*
D000894:Anti-Inflammatory Agents, Non-Steroidal; D000959:Antihypertensive Agents; D014662:Vasoconstrictor Agents; D014665:Vasodilator Agents; D012701:Serotonin; D011433:Propranolol; D000109:Acetylcholine; D009638:Norepinephrine; D007213:Indomethacin; D010646:Phentolamine